NxThera

About:

NxThera develops medical technologies to treat a variety of endourology conditions, including BPH.

Top Investors: Boston Scientific, Arboretum Ventures, Aberdare Ventures, Mitsui Global Investment, American Medical Systems

Description:

NxThera develops medical technologies to treat a variety of endourology conditions, including BPH. The company's technology platform utilizes a simple, minimally invasive, vapor therapy designed to measurably improve urinary flow and patient quality of life. BPH afflicts more than 32 million men in the United States.

Total Funding Amount:

$123M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Maple Grove, Minnesota, United States

Founded Date:

2008-01-01

Contact Email:

info(AT)nxthera.com

Founders:

Michael Hoey

Number of Employees:

11-50

Last Funding Date:

2017-07-19

IPO Status:

Private

Industries: